XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - Immunization, Realm US

19,481 resources

By Version

R2: 0
R2B: 0
R3: 524
R4: 18,515
R4B: 4
R5: 438
R6: 0

By Authority

none: 1,998
hl7: 17,481
national: 2

Start Prev Rows 6800 - 7000 Next

Package	Version	Identity	Name/Title	Status	Date	Auth
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.324	Severe Preeclampsia	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.326	Mild or Moderate Preeclampsia	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.327	Severe Preeclampsia	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.329	Mild or Moderate Preeclampsia	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.330	Hypertension	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.332	Hypertension	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.333	Renal Disease	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.335	Renal Disease	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.336	Gastrointestinal Disease	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.338	Gastrointestinal Disease	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.339	Cardiac Disease	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.341	Cardiac Disease	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.344	Aortic Aneurysm	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.357	Conversion of Cardiac Rhythm	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.358	Hysterectomy	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.359	Tracheostomy	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.360	Ventilation	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.361	Venous Thromboembolism in Pregnancy	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.363	Venous Thromboembolism in Pregnancy	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.364	Long Term Anticoagulant Use	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.366	Long Term Anticoagulant Use	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.368	Preadmission Observation Undelivered Mother	active	2021-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.369	ED Visit and OB Triage	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.370	Present on Admission is No or Unable To Determine	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.371	COVID 19 Confirmed	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.372	COVID 19 Confirmed	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.373	COVID 19 Confirmed	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.374	Respiratory Conditions Related to COVID 19	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.375	Respiratory Conditions Related to COVID 19	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.376	Respiratory Conditions Related to COVID 19	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.377	Respiratory Support Procedures	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.378	Respiratory Support Procedures	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.379	Respiratory Support Procedures Related to COVID 19	active	2022-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.387	Placenta Increta or Percreta	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1029.388	Placenta Increta or Percreta	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.10	Non essential Hypertension SNOMEDCT	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.12	Cirrhosis ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.151	Polycystic Ovary Syndrome	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.16	Low Intensity Statin Therapy/Branded	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.17	Moderate Intensity Statin Therapy/Branded	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.18	High Intensity Statin Therapy/Branded	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.233	All Results of High Risk HPV Test	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.234	High Risk HPV Positive Results	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.263	High Risk Positive HPV Results Without HPV16 or HPV18	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.268	HPV Negative Results	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.27	Non pharmacologic treatments for chronic pain ICD10PCS	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.29	Non pharmacologic treatments for chronic pain SCT	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.298	Cervical Cytology Test	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.299	HPV 16 Tests	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.300	HPV 18 Tests	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.305	Counseling for Physical Activity CPT	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.306	Counseling for Physical Activity ICD10CM	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.307	Counseling for Physical Activity CDS	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.322	Test 123	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.34	Opioid pain medications	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.36	Non pharmacologic treatments for chronic pain	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.40	Suicide attempt	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.42	Naloxone and Nalmefene medications	active	2024-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.43	Benzodiazepine medications	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.44	Stool softeners and laxatives	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.47	Anxiety	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.48	Anxiety	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.50	Sleep disordered breathing	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.51	Sleep disordered breathing	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.52	Anxiety	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.53	Sleep disordered breathing	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.54	Adjuvant pain medications	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.6	Non essential Hypertension ICD9CM	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.7	Non essential Hypertension ICD10CM	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.79	Behavioral Counseling for Nutrition and Activity Referral	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.85	Impaired Glucose Tolerance	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.87	Fasting Plasma Glucose	active	2023-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.88	Waist Circumference	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.9	Hypertension	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.92	First Degree Family Member	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1032.94	Glucose Tolerance Test Results	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.555	Patient Declines Treatment for Cluster Headache (SNOMEDCT)	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.558	Acute Cluster Headache Medication (RXNORM)	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.559	Long Term Preventive Medication for Cluster Headache	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.569	Migraine Preventive Medication	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.601	Acute Migraine Attack Medication	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.605	NSAID OTC Migraine Attack Medication	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.606	NSAID Prescribable Migraine Attack Medication	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.641	Neuromodulation for migraine	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.642	No pain with headache	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.643	Antiplatelets	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.644	Anticoagulants	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.645	Statin Medications	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.646	Anxiety Disorders (ICD10 and SNOMED)	active	2023-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.648	Depression Diagnosis (ICD10 and SNOMED)	active	2023-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.649	Psychosis (ICD10 and SNOMED)	active	2023-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.650	Cluster Headache (SNOMED)	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.651	Galcanezumab (RxNorm)	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.652	Lithium (RxNorm)	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.653	Verapamil	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.654	Long term preventive medications for cluster headache	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.655	Short term preventive medication for cluster headache	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.656	Zolmitriptan	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.657	Sumatriptan	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.658	Dihydroergotamine	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.659	Acute cluster headache medication	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.660	Acute cluster headache treatment	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.661	Short term preventive treatment for cluster headache	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.662	Long term preventive treatment for cluster headache	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.663	Migraine diagnosis (ICD)	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1034.664	Prescribable NSAIDs and Acute Migraine Attack Medication	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.103	Abnormal Presentation	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.105	Abnormal Presentation	active	2021-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.130	Respiratory Rate	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.15	Intravenous Thrombolytic tPA Therapy	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.16	Intraarterial Thrombolytic tPA Therapy	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.163	Systolic Blood Pressure	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.171	Abnormal Presentation	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.173	Delivery of Singleton	active	2021-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.21	Intravenous or Intraarterial Thrombolytic tPA Therapy	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.26	Estimated Gestational Age at Delivery	active	2021-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.27	Cornual Ectopic Pregnancy	active	2021-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.38	General Or Neuraxial Anesthesia	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.39	Low Dose Unfractionated Heparin for VTE Prophylaxis	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.41	Glycoprotein IIb IIIa Inhibitors	active	2023-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.55	Oxytocin	active	2021-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.56	Dinoprostone	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.58	Delivery Procedures	active	2021-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.59	Delivery Procedures	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.67	PCI	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.68	Endotracheal Intubation	active	2018-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.69	Endotracheal Intubation	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.98	Delivery of Singleton	active	2021-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1045.99	Delivery of Singleton	active	2021-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.225	Opioid Medication Assisted Treatment (MAT) SNOMED	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.241	Schedule II, III and IV Opioid Medications	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.242	Opioid Use Disorder	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.243	Opioid Use Disorder	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.265	Inpatient, Emergency, and Observation Locations	active	2022-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.269	Medications for Opioid Use Disorder (MOUD)	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.274	NHSN Inpatient Encounter Class Codes	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.277	Emergency Department Location	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.278	Emergency Department Treatment Location	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.283	Emergency Department Location	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.284	Emergency Department Location	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.285	Mental Health Diagnosis without Substance Use Disorders	active	2024-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.286	Decision to Transfer	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1046.35	Healthcare Agent or Proxy Choices	active	2022-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.10	Breastfeeding	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.100	Familial Hypercholesterolemia	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.102	Rhabdomyolysis	active	2017-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.107	Low Intensity Statin Therapy	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.12	Liver Disease	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.13	Rhabdomyolysis	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.19	Atherosclerosis and Peripheral Arterial Disease	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.20	Atherosclerosis and Peripheral Arterial Disease	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.21	Atherosclerosis and Peripheral Arterial Disease	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.22	Liver Disease ICD9	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.37	Stable and Unstable Angina	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.39	Cerebrovascular Disease Stroke or TIA	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.41	Ischemic Heart Disease or Related Diagnoses	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.42	Liver Disease	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.43	Liver Disease	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.44	Cerebrovascular Disease Stroke or TIA	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.46	Ischemic Heart Disease or Related Diagnoses	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.47	Stable and Unstable Angina	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.501	Overweight or Obese	active	2025-01	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.502	Overweight or Obese	active	2018-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.512	Elevated Blood Pressure Reading	active	2019-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.513	Elevated Blood Pressure Reading	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.514	Finding of Elevated Blood Pressure or Hypertension	active	2019-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.515	Bariatric Procedures	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.517	Age related macular degeneration intermediate dry	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.518	Ophthalmologist visit	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.519	Posterior vitreous detachment (PVD)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.521	Ophthalmoscopic exam	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.523	Opthalmoscopic exams with Scleral Depression	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.525	Referral (ophthalmology)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.526	Retina Ultrasound	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.527	Retina visualization inadequate	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.528	Refusal or Noncompliance with treatment	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.529	Vitreous hemorrhage	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.530	Vitreous hemorrhage	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.536	Macula examination	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.539	Fluorescein angiography	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.541	Optical coherence tomography (OCT)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.542	Intravitreal injection	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.543	Bevacizumab injection	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.544	Ranibizumab injection	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.545	Aflibercept injection	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.552	Uveitis	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.553	Uveitis	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.554	Post Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edema	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.555	Macular edema	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.556	Corticosteroids for Injection	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.557	Corticosteroids for Injection	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.560	Tonometry	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.561	Intraocular pressure	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.571	Retinal Vein Occlusion Related Macular Edema	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.576	Vitreous hemorrhage	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.580	Intravitreal and Periocular Injections	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.581	Intravitreal and Periocular Injections	active	2022-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.582	Corticosteroids for Injection	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.583	Endophthalmitis in the Right Eye	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.584	Endophthalmitis in the Left Eye	active	2020-03	hl7